$PETV News

PETVIVO ANNOUNCES RELEASE OF TWO REASEARCH ABSTRACTS AND UPCOMING CONFERENCE PRESENTATIONS ON OSTEOARTHRITIS IN RHESUS MACAQUES

Michael Handley Joins PetVivo Holdings, Inc. Board of Directors

Jaime Pickett Joins PetVivo Holdings, Inc. Board of Directors

PetVivo Hldgs Q1 2026 Earnings Call Transcript

PETVIVO ANIMAL HEALTH, INC. RELEASES CONFERENCE AND EXHIBIT SCHEDULE FOR 2026-2027

PETVIVO HOLDINGS ANNOUNCES NAME CHANGE OF HUMAN SUBSIDIARY TO SOMATRIX TECHNOLOGIES, INC. AND EXPANDS FOCUS ON HUMAN HEALTH INNOVATION

PetVivo Holdings Inc (PETV) (Q1 2027) Earnings Call Highlights: Revenue Growth and Strategic ...

PetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027

PetVivo Holdings, Inc. (PETV) Q1 2027 Earnings Call Transcript

PetVivo Holdings Q1 EPS $(0.05) Up From $(0.10) YoY, Sales $337.572K Up From $297.500K YoY

PetVivo Sets Fiscal First Quarter 2027 Conference Call for Friday, August 14, 2026 at 5:00 p.m. ET

PETVIVO HOLDINGS ANNOUNCES TERMINATION AND SETTLEMENT AGREEMENT WITH VETSTEM

PetVivo Reaches Settlement With VetStem, Terminates PrecisePRP License Agreement; PetVivo's Sole Remaining Financial Obligation Under The Settlement Agreement Is The Payment Of An Aggregate Of $75,000, Consisting Of Two Scheduled Cash Payments

PetVivo Holdings Announces Publication of Peer-Reviewed Clinical Study Evaluating Spryng® in Veterinary Record

PetVivo Holdings Announces Peer-Reviewed Data Publication For Spryng Canine Osteoarthritis And Cranial Cruciate Ligament Disease Treatment

Transcript: PetVivo Hldgs Q4 2026 Earnings Conference Call

PetVivo Holdings Inc (PETV) Q4 2026 Earnings Call Highlights: Navigating Growth Amidst Challenges

PetVivo Reports Financial and Operational Results for Fiscal 2026

PetVivo Hldgs Q4 EPS $(0.11), Same YoY, Sales $254.715K Up From $224.750K YoY

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026